We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+7.33%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$12.7B
AUM Growth
-$159M
Cap. Flow
+$1.08B
Cap. Flow %
8.52%
Top 10 Hldgs %
10.09%
Holding
527
New
73
Increased
203
Reduced
139
Closed
69

Top Sells

Rank Stock Value
1
BURL icon
Burlington
BURL
+$70.3M
2
WCN
Waste Connections
WCN
+$61.3M
3
AYI icon
Acuity Brands
AYI
+$56.2M
4
JBLU icon
JetBlue
JBLU
+$54.3M
5
MLM icon
Martin Marietta Materials
MLM
+$53.3M

Sector Composition

Rank Sector Weight
1 Healthcare 19.28%
2 Technology 18.45%
3 Industrials 14.15%
4 Consumer Discretionary 14.07%
5 Financials 10.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNPS icon
126
Synopsys
SNPS
$73.5B
$36.7M 0.29%
428,365
+63,815
+18% +$5.56M
TRIP icon
127
TripAdvisor
TRIP
$1.74B
$36.4M 0.29%
654,045
+145,616
+29% +$6.96M
ISRG icon
128
Intuitive Surgical
ISRG
$130B
$36M 0.28%
225,597
+3,636
+2% +$554K
TREE icon
129
LendingTree
TREE
$572M
$35.6M 0.28%
171,688
+4,349
+3% +$1.21M
HZO icon
130
MarineMax
HZO
$782M
$35.3M 0.28%
1,861,655
+67,605
+4% +$1.46M
MKTX icon
131
MarketAxess Holdings
MKTX
$4.34B
$35.3M 0.28%
178,277
+23,686
+15% +$4.91M
XEL icon
132
Xcel Energy
XEL
$50.1B
$35.3M 0.28%
+772,125
New +$34.6M
TVTY
133
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$35M 0.28%
992,903
+222,724
+29% +$8.22M
APH icon
134
Amphenol
APH
$177B
$34.9M 0.27%
1,600,504
+188,448
+13% +$4.1M
PODD icon
135
Insulet
PODD
$11.6B
$34.7M 0.27%
404,355
+9,372
+2% +$841K
SF
136
Stifel
SF
$12.8B
$34.6M 0.27%
1,491,305
LITE icon
137
Lumentum
LITE
$50.7B
$34.4M 0.27%
594,857
SLAB icon
138
Silicon Laboratories
SLAB
$7.17B
$34.4M 0.27%
345,467
+66,931
+24% +$6.69M
EVH icon
139
Evolent Health
EVH
$421M
$34.4M 0.27%
1,633,453
+687,893
+73% +$13M
APTV icon
140
Aptiv
APTV
$12.6B
$34M 0.27%
371,612
+73,326
+25% +$6.84M
CWH icon
141
Camping World
CWH
$399M
$33.3M 0.26%
1,331,687
+396,306
+42% +$9.88M
SPOT icon
142
Spotify
SPOT
$105B
$32.2M 0.25%
+191,174
New +$30.6M
DLTR icon
143
Dollar Tree
DLTR
$24.4B
$31.9M 0.25%
375,644
+60,506
+19% +$5.58M
AXGN icon
144
Axogen
AXGN
$2.19B
$31.9M 0.25%
+635,364
New +$28M
XLRN
145
DELISTED
Acceleron Pharma
XLRN
$31.9M 0.25%
657,640
-285,204
-30% -$10.4M
PGNX
146
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$31.7M 0.25%
3,948,024
CHRW icon
147
C.H. Robinson
CHRW
$20B
$31.1M 0.24%
371,444
+54,358
+17% +$4.85M
ZGNX
148
DELISTED
Zogenix, Inc.
ZGNX
$30.7M 0.24%
693,531
ZAYO
149
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$30.6M 0.24%
838,172
+137,166
+20% +$4.89M
FHN icon
150
First Horizon
FHN
$12.3B
$30.1M 0.24%
1,686,450
+252,725
+18% +$4.76M

Similar funds

Carillon Tower Advisers's Q2 2018 Portfolio in Review

As of Q2 2018, Carillon Tower Advisers held 527 positions worth $12.7B, down 1.2% from $12.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Carillon Tower Advisers deployed $1.08B of net new capital in Q2 2018, opening 73 new positions and adding to 203 existing holdings. Its largest new stake was WW International: 726,252 shares worth $73.4M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Burlington, an estimated $70.3M trimmed.

  • Carillon Tower Advisers's largest Q2 2018 buy was WW International: 726,252 shares worth $73.4M.
  • Carillon Tower Advisers added most to Abiomed Inc in Q2 2018, an estimated $63.1M increase.
  • Carillon Tower Advisers's biggest Q2 2018 reduction was Burlington, cutting an estimated $70.3M.
  • Carillon Tower Advisers fully exited Acuity Brands in Q2 2018, selling an estimated $56.2M.
  • Carillon Tower Advisers's ten largest holdings make up 10% of its $12.7B portfolio in Q2 2018.
  • Carillon Tower Advisers opened 73 new positions and closed 69 in Q2 2018.
  • Carillon Tower Advisers's portfolio value fell 1.2% quarter-over-quarter to $12.7B.

Based on Carillon Tower Advisers's 13F filing for Q2 2018, filed 9 Aug 2018.